The review highlights the transition in understanding congenital myopathies from purely morphological classifications to incorporating specific molecular genetic defects.
Answers are grounded in this paper and cite their sources.
May aid genetic diagnosis of congenital myopathies; leaves open prospective genotype-phenotype validation in clinical cohorts.
Most congenital myopathies have been defined on account of the morphological findings in enzyme histochemical preparations. In effect, the diagnosis of this group of diseases continues to be made on the histological pattern of muscle biopsies. However, progress has been made in elucidating the molecular genetic background of several of the congenital myopathies. In this updated review we address those congenital myopathies for which gene defects and mutant proteins have been found (central core disease, nemaline myopathies, desminopathy, actinopathy, certain vacuolar myopathies, and myotubular myopathy) and the other disease with central nuclei (centronuclear myopathy).
No takes yet. Share an insight, caveat, or question.
Bornemann et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: